HEC Placebo gel
HEC Placebo gel is an intervention with 9 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
8
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Rectal Safety and Acceptability Study of Tenofovir 1% Gel
The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy
Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms
A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04
Microbicide Safety and Acceptability in Young Men
Clinical Trials (9)
Rectal Safety and Acceptability Study of Tenofovir 1% Gel
The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy
Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms
A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04
Microbicide Safety and Acceptability in Young Men
Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females
Safety and Acceptability of SPL7013 Gel (VivaGel™) in Sexually Active Women
Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Enhanced MRI Techniques to Increase Resolution
An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots
All 9 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 9